NVS Related Analyst Comments

May 20, 2013 11:43 AM UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Nov 21, 2012 08:37 AM Investors Willing to Wait on Novartis (NVS) Could Reap Dividends - Barron's

Sep 12, 2012 07:52 AM Jefferies on Pharmaceutical: Top Picks Still ABT and NVS

Aug 24, 2012 08:05 AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 5, 2012 10:47 AM Wells Fargo on Biogen (BIIB): Price Increases in MS Space Should Offer More Flexibility for BG-12

Jul 5, 2012 09:58 AM Elan Corp (ELN) Has Mutlipe Items Driving Action Today

May 9, 2012 10:40 AM Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness

Apr 23, 2012 08:06 AM Jefferies Maintains a 'Buy' on Biogen (BIIB); Favorable Gilenya Update

Jan 9, 2012 09:33 AM Jefferies Raises Price Targets on Global Pharma Industry, Sets Top Picks of the Year

Oct 6, 2011 12:29 PM Shares of Anadys (ANDS) Trade Above $1; Analyst Believes Co. Could Get a Bid Following Setrobuvir Data

Sep 19, 2011 04:00 PM Leerink Swann Cuts Valuation on Momenta Pharmaceuticals (MNTA), Competition Increases

Aug 1, 2011 08:12 AM Needham & Company Maintains a 'Buy' on Regeneron Pharma (REGN); Upcoming August Event May Signal August Opportunities

Jul 20, 2011 09:16 AM Jefferies Cuts Price Target on Gen-Probe (GPRO) as Novartis (NVS) No Longer Looks to Buy

Jun 20, 2011 10:20 AM Eli Lilly (LLY) Might Be M&A Target if Things Don't Shape Up

Jun 9, 2011 08:19 AM Elan (ELN) Shares Surge as UBS Upgrades to Buy Amid Strong Tysabri Sales; Adds Stock to 'Key Calls List'

May 16, 2011 02:05 PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine

May 12, 2011 02:19 PM Barclays on Global Pharmaceuticals: Global Therapeutic Conference Preview: Multiple Sclerosis

Mar 7, 2011 02:16 PM Barclays on Healthcare Services: Weekly Flu Clues Review

Feb 9, 2011 11:14 AM Canaccord Genuity Morning Coffee on Teva Pharma (TEVA): Well, At Least It’s Not In Egypt.

Feb 2, 2011 01:20 PM Barclays Reiterates an 'Overweight' on Array BioPharma (ARRY); Reports FY2Q11, Data for MEK inhibitors in 2011

Dec 17, 2010 03:00 PM Barclays Maintains an 'Equalweight' on Elan Corp (ELN); Strong Gilenya Start May Translate to Tysabri Weakness

Dec 17, 2010 02:56 PM Barclays Maintains an 'Equalweight' on Biogen (BIIB); IMPACT RX Data Suggest Strong Gilenya Launch

Nov 2, 2010 03:30 PM Canaccord Genuity Morning Coffee on Avanir Pharma (AVNR): Approved – Game On!

Oct 12, 2010 08:52 AM Morgan Joseph Reiterates a 'Buy' on ImmunoGen (IMGN); Deal Brings Unprecedented Financial Stability

Sep 15, 2010 02:38 PM Leerink Swann Raises Target on Savient (SVNT) to $22; Highlights Takeover Potential Following Krystexxa Approval

Jul 27, 2010 10:36 AM Citi Maintains a 'Buy' Rating on Alcon (ACL); First Look - Strong 2Q

Jul 26, 2010 01:02 PM Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed

Jul 15, 2010 09:15 AM Citi Maintains a 'Buy' on Alcon Inc (ACL); Independent Directors Make A Compelling Case

Jul 2, 2010 10:38 AM UBS Maintains a 'Neutral' on PharMerica (PMC); Generic Exelon Mild Positive

Apr 20, 2010 12:07 PM Human Genome (HGSI) Slammed After BENLYSTA Fails To Hit Secondary Endpoints and European JOULFERON Application Pulled

Dec 2, 2009 03:06 PM Despite Novartis Denial, UBS Makes A Strong Case That They Should Buy Alcon (ACL)

Jul 8, 2009 09:12 AM Piper Jaffray Reiterates an 'Overweight' on Regeneron Pharmaceuticals (REGN); Raises Price Target

Mar 18, 2009 08:18 AM Goldman Sachs Added Novartis AG (NVS) To Buy List, GlaxoSmithKline (GSK) To Sell List

Feb 24, 2009 09:28 AM Collins Stewart Reiterates a 'Buy' Rating on Alcon (ACL), Expects Novartis (NVS) to Acquire Additional Stake

Sep 10, 2008 10:19 AM Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News

Jun 13, 2007 07:28 AM Jim Cramer Makes Positive Comments on WYE and NVS

Oct 31, 2006 09:03 AM Needham Comments on Other Stocks in RNAi Following Merck's Deal to Buy Sirna Therapeutics

Jun 8, 2006 12:19 AM Citigroup Addresses Concerns on Human Genome Sciences (HGSI)

Dec 7, 2005 10:09 AM Piper Jaffray Comments on Speculation NVS/CHIR Could Sell Blood Testing Business to GPRO

Sep 9, 2005 08:25 AM Lehman Expects NVS to Raises CHIR Bid to $45

Sep 7, 2005 11:02 AM Piper Jaffray Raises its Price Target on ANLY to $17

Jul 11, 2005 11:22 AM Needham Raises its Price Target on ANDS

Jun 2, 2005 02:35 PM Piper Jaffray Raises Price Target on ANDS To $15